Showing posts with label
FDA approvals
.
Show all posts
Showing posts with label
FDA approvals
.
Show all posts
Monday, January 12, 2026
Why we own BEAM Therapeutics - update January 2026
›
Beam Therapeutics (NASDAQ: BEAM) Updated Investment & Business Report – January 2026 Theme: Precision genetic medicine through base...
Tuesday, July 29, 2025
Comprehensive Business & Investment Report: BiomX Inc. (NYSE: PHGE) bacteriophage (Phage) based therapies targeting chronic and resistant bacterial infections!
›
1. Executive Summary BiomX Inc. is a clinical-stage biotechnology company pioneering in the development of bacteriophage-based therapies t...
›
Home
View web version
